HomeNXG • CVE
add
NexgenRx Inc
Previous close
$0.20
Year range
$0.18 - $0.33
Market cap
14.18M CAD
Avg Volume
12.31K
P/E ratio
-
Dividend yield
5.00%
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 3.57M | 5.74% |
Operating expense | 3.00M | 6.78% |
Net income | -387.58K | -5.95% |
Net profit margin | -10.85 | -0.28% |
Earnings per share | — | — |
EBITDA | 50.84K | 8.46% |
Effective tax rate | -32.02% | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.88M | 6.22% |
Total assets | 30.20M | 17.28% |
Total liabilities | 22.48M | 33.06% |
Total equity | 7.71M | — |
Shares outstanding | 70.53M | — |
Price to book | 2.22 | — |
Return on assets | -2.11% | — |
Return on capital | -7.38% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -387.58K | -5.95% |
Cash from operations | 397.36K | 182.13% |
Cash from investing | -11.87K | -103.75% |
Cash from financing | -445.96K | -644.51% |
Net change in cash | -60.47K | 73.35% |
Free cash flow | 546.84K | 112.83% |
About
Founded
2003
Headquarters
Website
Employees
20